Compare CBNK & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CBNK | THW |
|---|---|---|
| Founded | 1974 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Finance Companies |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 560.3M | 516.7M |
| IPO Year | 2018 | 2015 |
| Metric | CBNK | THW |
|---|---|---|
| Price | $35.45 | $13.25 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $35.50 | N/A |
| AVG Volume (30 Days) | 65.1K | ★ 160.9K |
| Earning Date | 04-27-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.52% | N/A |
| EPS Growth | ★ 60.85 | N/A |
| EPS | ★ 0.73 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.20 | N/A |
| Revenue Next Year | $8.52 | N/A |
| P/E Ratio | $49.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.40 | $10.60 |
| 52 Week High | $37.00 | $13.79 |
| Indicator | CBNK | THW |
|---|---|---|
| Relative Strength Index (RSI) | 56.73 | 53.24 |
| Support Level | $34.27 | $12.33 |
| Resistance Level | $36.41 | $13.79 |
| Average True Range (ATR) | 1.04 | 0.23 |
| MACD | -0.07 | -0.04 |
| Stochastic Oscillator | 43.59 | 27.74 |
Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage. The company generates majority revenue from the Commercial bank sector. Commercial Banking division focuses on providing personalized service to commercial clients throughout the operations supplemented by lending outside primary market as well as engaging in government guaranteed lending on a national basis.
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.